PainNCT05177263
Effects of the Different Concentrations of Oral Dextrose Solution Applying With Supportive Positions on Pain During Heel-Stick Sampling in Premature Infants
A study testing 10% Oral Dextrose Solution, 20% Oral Dextrose Solution and 30% Oral Dextrose Solution in people with Pain, run by Guzide UGUCU at 1 site in Turkey (Türkiye).
Trial summary
Within the scope of the newborn screening (metabolic and endocrine diseases) tests (NSTs), this research aims to determine the effect of the different concentrations of oral dextrose solution applying together with supportive positions primarily on the pain scores and secondarily on the duration of crying time during… Read more about this study
- Who is it for?
- Ages 2 to 7 days
- Conditions the study is for
- Pain
- What is being tested?
- 10% Oral Dextrose Solution, 20% Oral Dextrose Solution and 30% Oral Dextrose Solution
- Type of treatment
- Pill or oral medicine
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 128 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 6 Jun 2022to 1 Sep 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 2 to 7 days
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- Gestational age (GA) at birth 33+0 - 37+0 weeks
- Admitted to NICU
- Planned the heel-stick sampling within the scope of the NSTs
- Parents are able to read, write and speak Turkish
Who cannot join
- With a postnatal age of 8 days or more
- Has contraindications for the administration of oral glucose (genetic, endocrine, metabolic diseases or neurological problems etc.)
- Has major congenital anomalies
- Has intubated or receiving a nCPAP
- Has received analgesics or sedatives for less than 24 hours before the procedure
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Mersin University Hospital
Mersin, Yenişehir, 33
About this study
Official title: Effect of the Different Concentrations of Oral Dextrose Solution Applying Together With Supportive Positions on Pain During the Heel-Stick Sampling in Premature Infants: A Randomized Controlled Study
Within the scope of the newborn screening (metabolic and endocrine diseases) tests (NSTs), this research aims to determine the effect of the different concentrations of oral dextrose solution applying together with supportive positions primarily on the pain scores and secondarily on the duration of crying time during the heel-stick sampling in premature infants.
Read the detailed description
Background Premature infants admitted to the neonatal intensive care unit (NICU) experience pain most frequently due to heel-stick sampling, venipuncture, and peripheral IV placement. The heel-stick method for drawing capillary blood is the most common way to draw newborns' blood. It is used to collect blood for newborn screening tests, usually on the 2nd-7th days after birth. Heel-stick sampling is known to cause moderate to severe pain in premature infants. There is a lack of high-quality evidence in the relevant studies determining effective interventions in the management of pain caused by heel-stick sampling in premature babies.
Research Hypotheses H01: There is no difference in the mean N-PASS scores during the procedure between the groups.
H02: There is no difference in the mean N-PASS scores after the procedure between the groups.
H03: There is no difference in the mean durations of crying after the procedure between the groups.
Design and Settings:This parallel-group randomized trial will be conducted in a Level 4a NICU at a university hospital. For this experimental research, 128 premature infants who will be screened with the routine NSTs are enrolled and randomized into four groups one control group with "supportive positions + oral sterile water (n=32)", one group with "supportive positions + 10% oral dextrose (n=32)", "supportive positions + 20% oral dextrose (n=32)", "supportive positions + 30% oral dextrose (n=32)". The hospital provides education in the field of neonatal nursing (certification) and neonatology (sub-specialty) as a training hospital. The 25-bed unit is one of the tertiary care referral centers in the East Mediterranean Region of Turkey. The admission rate is nearly 214 infants per year on average. Generally, infants come from peripheral (40%), and central (40%) districts, or another city (20%). The unit design is a traditional open-bay type. Heel-stick sampling in premature infants is carried out on the 2nd-10th days after birth within the scope of the NSTs. The Turkish version of the Neonatal Pain Agitation and Sedation Scale (N-PASS) is used as a pain assessment tool in nursing forms. Pain scores of premature infants are evaluated and recorded at each shift change and interventional procedure.
Sample Size: A priori power analysis was used to estimate the sample size based on data from "Brovedani, P., Montico, M., Shardlow, A., Strajn, T., \& Demarini, S. (2007). Suckling and sugar for pain reduction in babies. The Lancet, 369(9571), 1429-1430." A priori power analysis was performed based on the effect size (d = 0.929, large effect) of the difference in pain scores between the groups (during the procedure) determined in this study. The minimum sample size was calculated as 104 premature infants, with 26 infants per group, for a two-tailed hypothesis, an effect size of d = 0.929, an allocation ratio of 1:1, type I error of 0.05, and a power of 90%. Considering that there may be drop-outs during the process, the number of groups was increased by 20%. The sample size of this study was determined as 128 premature infants (32 premature infants in each intervention group).
Data Collection Tools Premature Infant's Information and Observation Form: This form was developed by the researchers after the literature review. It contains variables including gestational age at birth, postnatal age, birth weight, sex, procedural pain experience within the 24 hours prior to the intervention, the number of punctures performed during the intervention, duration of the intervention, duration of crying, the occurrence of adverse events during the intervention, heart rate, respiratory rate, saturation, and N-PASS score of premature infants before, during, and after the intervention.
Neonatal Pain Agitation and Sedation Scale - NPASS: Developed by Hummel et al. (2007, 2010), the Turkish validity-reliability study of this scale was conducted by Açıkgöz et al. (2017) and it is used for the quantitative assessment of acute, prolonged, chronic and postoperative pain in the first 100 days of life starting from the 23rd week of gestational age. The N-PASS is comprised of two measurements, each of which uses five criteria: crying/irritability, behavioral state, facial expression, extremity tone and vital signs. The pain score is assessed through observation without intervention, with a score range of 0 to 10, with 0 to 2 points available for each criterion. Points are added to the preterm infant's pain score (<28 weeks (3 points), 28-31 weeks (2 points), and 32-35 weeks (1 point)) to approximate the normal response of a full-term infant. Higher values represent higher pain.
Intervention: For each group, supportive positions are the facilitated flexion, nesting, and midline positions. Soft blankets and pillows will be used for positioning and nesting. The premature infants will be safely swaddled with a blanket supporting the natural fetal position that facilitated flexion and midline position. The enrolled premature infants will be administered 1ml of the oral solution a first time 2 minutes before the procedure. After 2 minutes, heel-stick sampling (with an auto lancet for premature infants) will be performed immediately after administering 1 ml of oral solution a second time. The infant's face and the monitor screen will be recorded in real-time using two independent video cameras during the entire procedure (starting 3 minutes prior to heel-stick sampling and continuing until the infant's crying is over). The N-PASS will be assessed during heel punction, at 1st minute, and 2nd minute after the procedure. After the end of the procedure, the recordings will be evaluated by two nurses, independent from each other. Oxygen saturation, heart rate and crying time will be determined from video recordings.
Ethical Considerations: The study was granted approval by the clinical research ethics committee and written institutional permission by the hospital. Parents will be informed about the procedure and written consent will be obtained.
- Conditions
- Pain
- Being tested
- Placebo, 10% Oral Dextrose Solution, 20% Oral Dextrose Solution, 30% Oral Dextrose Solution
- Medical subject headings
- Pain
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
PlaceboOther
Sterile Water
10% Oral Dextrose SolutionDrug
Also called Sweet taste
10% Oral Dextrose Solution
20% Oral Dextrose SolutionDrug
Also called Sweet taste
20% Oral Dextrose Solution
30% Oral Dextrose SolutionDrug
Also called Sweet taste
30% Oral Dextrose Solution
| Study group | Role | What they receive |
|---|---|---|
| Supportive Positions + Oral Sterile Water | Placebo comparator | The enrolled premature infants will be administered 1ml of the sterile water a first time 2 minutes before the procedure. After 2 minutes, heel-stick sampling (with an auto lancet for premature infants) will be performed immediately after administering 1 ml of sterile water a second time. Receives: Other: Placebo |
| Supportive Positions + 10% Oral Dextrose | Active comparator | The enrolled premature infants will be administered 1ml of the 10% oral dextrose solution a first time 2 minutes before the procedure. After 2 minutes, heel-stick sampling (with an auto lancet for premature infants) will be performed immediately after administering 1 ml of 10% oral dextrose solution a second time.
(%10 oral dextrose solution: osmolarity= 550 mOsm/L, pH= 3.5-6.5, calorie=400 kcal/L) Receives: Drug: 10% Oral Dextrose Solution |
| Supportive Positions + 20% Oral Dextrose | Active comparator | The enrolled premature infants will be administered 1ml of the 20% oral dextrose solution a first time 2 minutes before the procedure. After 2 minutes, heel-stick sampling (with an auto lancet for premature infants) will be performed immediately after administering 1 ml of 20% oral dextrose solution a second time.
(%20 oral dextrose solution: osmolarity= 1010 mOsm/L, pH= 3.2-6.5, calorie= 680 kcal/L) Receives: Drug: 20% Oral Dextrose Solution |
| Supportive Positions + 30% Oral Dextrose | Active comparator | The enrolled premature infants will be administered 1ml of the 30% oral dextrose solution a first time 2 minutes before the procedure. After 2 minutes, heel-stick sampling (with an auto lancet for premature infants) will be performed immediately after administering 1 ml of 30% oral dextrose solution a second time.
(%30 oral dextrose solution: osmolarity= 1515 mOsm/L, pH= 3.2-6.5, calorie= 1020 kcal/L) Receives: Drug: 30% Oral Dextrose Solution |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pain will be measured by N-PASS
It is scored with 0 to 2 points available for each criterion (crying/irritability, behavioral state, facial expression, extremity tone and vital signs) and ranged from 0 to 10. Higher values represent higher pain.
Measured: at the heel punction during heel-stick sampling
Pain will be measured by N-PASS
It is scored with 0 to 2 points available for each criterion (crying/irritability, behavioral state, facial expression, extremity tone and vital signs) and ranged from 0 to 10. Higher values represent higher pain.
Measured: at 1st minute after the heel punction
Pain will be measured by N-PASS
It is scored with 0 to 2 points available for each criterion (crying/irritability, behavioral state, facial expression, extremity tone and vital signs) and ranged from 0 to 10. Higher values represent higher pain.
Measured: at 2st minute after the heel punction
Secondary outcomes (1)
Duration of crying will be documented by video recordings
Total amount of time (in minutes) the infant is crying during the procedure.
Measured: The total crying time is measured from where it starts until the over.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Jan 2022
- Study start6 Jun 2022
- Primary completion8 Jun 2023
- Study completion1 Sep 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for PainStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind
- Who is masked
- Participant, Care provider, Investigator, Outcomes assessor
- Enrolment
- 128 participants (actual)
Sponsor and investigators
- Lead sponsor
- Guzide UGUCU
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Guzide UGUCU, Mersin University
- Investigators
- Guzide UGUCU, Principal investigator, Mersin University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05177263
- Sponsor's protocol ID
- MersinU*GUGUCU_002
- Status last verified
- Sep 2024
- First submitted
- 15 Dec 2021
- Last updated
- 19 Sep 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: There is not a plan to make IPD available.
Publications
Ugucu G, Yigit R, Celik Y. Effect of combining oral glucose solutions with supportive positions on pain during heel puncture blood sampling in premature infants: A randomized quadruple-blinded experimental study. J Pediatr Nurs. 2024 Jul-Aug;77:e108-e116. doi: 10.1016/j.pedn.2024.03.038. Epub 2024 Apr 3.
PubMed 38570229
Study at a glance
From the registry record, last updated by the sponsor on 19 Sep 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of the Different Concentrations of Oral Dextrose Solution Applying Together With Supportive Positions on Pain During the Heel-Stick Sampling in Premature Infants: A Randomized Controlled Study
- ClinicalTrials.gov ID
- NCT05177263
- Acronym / sponsor ID
- MersinU*GUGUCU_002
- Conditions
- Pain
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 128 participants (actual)
- Lead sponsor
- Guzide UGUCUUniversity, hospital or other
- Study start
- 6 Jun 2022 (actual)
- Primary completion
- 8 Jun 2023 (actual)
- Study completion
- 1 Sep 2023 (actual)
- First posted
- 4 Jan 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Within the scope of the newborn screening (metabolic and endocrine diseases) tests (NSTs), this research aims to determine the effect of the different concentrations of oral dextrose solution applying together with supportive positions primarily on the pain scores and secondarily on the duration of crying time during the heel-stick sampling in premature infants.
Detailed description
Background Premature infants admitted to the neonatal intensive care unit (NICU) experience pain most frequently due to heel-stick sampling, venipuncture, and peripheral IV placement. The heel-stick method for drawing capillary blood is the most common way to draw newborns' blood. It is used to collect blood for newborn screening tests, usually on the 2nd-7th days after birth. Heel-stick sampling is known to cause moderate to severe pain in premature infants. There is a lack of high-quality evidence in the relevant studies determining effective interventions in the management of pain caused by heel-stick sampling in premature babies.
Research Hypotheses H01: There is no difference in the mean N-PASS scores during the procedure between the groups.
H02: There is no difference in the mean N-PASS scores after the procedure between the groups.
H03: There is no difference in the mean durations of crying after the procedure between the groups.
Design and Settings:This parallel-group randomized trial will be conducted in a Level 4a NICU at a university hospital. For this experimental research, 128 premature infants who will be screened with the routine NSTs are enrolled and randomized into four groups one control group with "supportive positions + oral sterile water (n=32)", one group with "supportive positions + 10% oral dextrose (n=32)", "supportive positions + 20% oral dextrose (n=32)", "supportive positions + 30% oral dextrose (n=32)". The hospital provides education in the field of neonatal nursing (certification) and neonatology (sub-specialty) as a training hospital. The 25-bed unit is one of the tertiary care referral centers in the East Mediterranean Region of Turkey. The admission rate is nearly 214 infants per year on average. Generally, infants come from peripheral (40%), and central (40%) districts, or another city (20%). The unit design is a traditional open-bay type. Heel-stick sampling in premature infants is carried out on the 2nd-10th days after birth within the scope of the NSTs. The Turkish version of the Neonatal Pain Agitation and Sedation Scale (N-PASS) is used as a pain assessment tool in nursing forms. Pain scores of premature infants are evaluated and recorded at each shift change and interventional procedure.
Sample Size: A priori power analysis was used to estimate the sample size based on data from "Brovedani, P., Montico, M., Shardlow, A., Strajn, T., \& Demarini, S. (2007). Suckling and sugar for pain reduction in babies. The Lancet, 369(9571), 1429-1430." A priori power analysis was performed based on the effect size (d = 0.929, large effect) of the difference in pain scores between the groups (during the procedure) determined in this study. The minimum sample size was calculated as 104 premature infants, with 26 infants per group, for a two-tailed hypothesis, an effect size of d = 0.929, an allocation ratio of 1:1, type I error of 0.05, and a power of 90%. Considering that there may be drop-outs during the process, the number of groups was increased by 20%. The sample size of this study was determined as 128 premature infants (32 premature infants in each intervention group).
Data Collection Tools Premature Infant's Information and Observation Form: This form was developed by the researchers after the literature review. It contains variables including gestational age at birth, postnatal age, birth weight, sex, procedural pain experience within the 24 hours prior to the intervention, the number of punctures performed during the intervention, duration of the intervention, duration of crying, the occurrence of adverse events during the intervention, heart rate, respiratory rate, saturation, and N-PASS score of premature infants before, during, and after the intervention.
Neonatal Pain Agitation and Sedation Scale - NPASS: Developed by Hummel et al. (2007, 2010), the Turkish validity-reliability study of this scale was conducted by Açıkgöz et al. (2017) and it is used for the quantitative assessment of acute, prolonged, chronic and postoperative pain in the first 100 days of life starting from the 23rd week of gestational age. The N-PASS is comprised of two measurements, each of which uses five criteria: crying/irritability, behavioral state, facial expression, extremity tone and vital signs. The pain score is assessed through observation without intervention, with a score range of 0 to 10, with 0 to 2 points available for each criterion. Points are added to the preterm infant's pain score (<28 weeks (3 points), 28-31 weeks (2 points), and 32-35 weeks (1 point)) to approximate the normal response of a full-term infant. Higher values represent higher pain.
Intervention: For each group, supportive positions are the facilitated flexion, nesting, and midline positions. Soft blankets and pillows will be used for positioning and nesting. The premature infants will be safely swaddled with a blanket supporting the natural fetal position that facilitated flexion and midline position. The enrolled premature infants will be administered 1ml of the oral solution a first time 2 minutes before the procedure. After 2 minutes, heel-stick sampling (with an auto lancet for premature infants) will be performed immediately after administering 1 ml of oral solution a second time. The infant's face and the monitor screen will be recorded in real-time using two independent video cameras during the entire procedure (starting 3 minutes prior to heel-stick sampling and continuing until the infant's crying is over). The N-PASS will be assessed during heel punction, at 1st minute, and 2nd minute after the procedure. After the end of the procedure, the recordings will be evaluated by two nurses, independent from each other. Oxygen saturation, heart rate and crying time will be determined from video recordings.
Ethical Considerations: The study was granted approval by the clinical research ethics committee and written institutional permission by the hospital. Parents will be informed about the procedure and written consent will be obtained.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind (participant, care provider, investigator, outcomes assessor)
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| Supportive Positions + Oral Sterile Water | Placebo comparator | Other: PlaceboThe enrolled premature infants will be administered 1ml of the sterile water a first time 2 minutes before the procedure. After 2 minutes, heel-stick sampling (with an auto lancet for premature infants) will be performed immediately after administering 1 ml of sterile water a second time. |
| Supportive Positions + 10% Oral Dextrose | Active comparator | Drug: 10% Oral Dextrose SolutionThe enrolled premature infants will be administered 1ml of the 10% oral dextrose solution a first time 2 minutes before the procedure. After 2 minutes, heel-stick sampling (with an auto lancet for premature infants) will be performed immediately after administering 1 ml of 10% oral dextrose solution a second time. (%10 oral dextrose solution: osmolarity= 550 mOsm/L, pH= 3.5-6.5, calorie=400 kcal/L) |
| Supportive Positions + 20% Oral Dextrose | Active comparator | Drug: 20% Oral Dextrose SolutionThe enrolled premature infants will be administered 1ml of the 20% oral dextrose solution a first time 2 minutes before the procedure. After 2 minutes, heel-stick sampling (with an auto lancet for premature infants) will be performed immediately after administering 1 ml of 20% oral dextrose solution a second time. (%20 oral dextrose solution: osmolarity= 1010 mOsm/L, pH= 3.2-6.5, calorie= 680 kcal/L) |
| Supportive Positions + 30% Oral Dextrose | Active comparator | Drug: 30% Oral Dextrose SolutionThe enrolled premature infants will be administered 1ml of the 30% oral dextrose solution a first time 2 minutes before the procedure. After 2 minutes, heel-stick sampling (with an auto lancet for premature infants) will be performed immediately after administering 1 ml of 30% oral dextrose solution a second time. (%30 oral dextrose solution: osmolarity= 1515 mOsm/L, pH= 3.2-6.5, calorie= 1020 kcal/L) |
Who may qualify
- Ages
- 2 to 7 days
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (4 listed)
- Gestational age (GA) at birth 33+0 - 37+0 weeks
- Admitted to NICU
- Planned the heel-stick sampling within the scope of the NSTs
- Parents are able to read, write and speak Turkish
Key exclusion criteria (5 listed)
- With a postnatal age of 8 days or more
- Has contraindications for the administration of oral glucose (genetic, endocrine, metabolic diseases or neurological problems etc.)
- Has major congenital anomalies
- Has intubated or receiving a nCPAP
- Has received analgesics or sedatives for less than 24 hours before the procedure
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| PlaceboSterile Water | Other | Supportive Positions + Oral Sterile Water |
| 10% Oral Dextrose SolutionAlso: Sweet taste10% Oral Dextrose Solution | Drug | Supportive Positions + 10% Oral Dextrose |
| 20% Oral Dextrose SolutionAlso: Sweet taste20% Oral Dextrose Solution | Drug | Supportive Positions + 20% Oral Dextrose |
| 30% Oral Dextrose SolutionAlso: Sweet taste30% Oral Dextrose Solution | Drug | Supportive Positions + 30% Oral Dextrose |
Primary outcome
Pain will be measured by N-PASS
Time frame: at the heel punction during heel-stick sampling
It is scored with 0 to 2 points available for each criterion (crying/irritability, behavioral state, facial expression, extremity tone and vital signs) and ranged from 0 to 10. Higher values represent higher pain.
Pain will be measured by N-PASS
Time frame: at 1st minute after the heel punction
It is scored with 0 to 2 points available for each criterion (crying/irritability, behavioral state, facial expression, extremity tone and vital signs) and ranged from 0 to 10. Higher values represent higher pain.
Pain will be measured by N-PASS
Time frame: at 2st minute after the heel punction
It is scored with 0 to 2 points available for each criterion (crying/irritability, behavioral state, facial expression, extremity tone and vital signs) and ranged from 0 to 10. Higher values represent higher pain.
1 secondary outcome
Duration of crying will be documented by video recordings
Time frame: The total crying time is measured from where it starts until the over.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Sep 2024.
- Results publication: PubMed 38570229Ugucu G, Yigit R, Celik Y. Effect of combining oral glucose solutions with supportive positions on pain during heel puncture blood sampling in premature infants: A randomized quadruple-blinded experimental study. J Pediatr Nurs. 2024 Jul-Aug;77:e108-e116. doi: 10.1016/j.pedn.2024.03.038. Epub 2024 Apr 3.
- Individual participant dataSharing planned: No. There is not a plan to make IPD available.
Related trials for Pain
Not yet recruiting
Effect of Stress Ball Use During Femoral Arterial Sheath Removal After Coronary Angiography
Femoral Arterial Sheath Removal, Stress Ball
Recruiting
Empowered Relief® for Cancer Survivors With Chronic Pain
Chronic Pain Due to Cancer, Pain Catastrophizing
RecruitingPhase 4
ESP Blocks for Posterior Spinal Fusion
Postoperative Pain
RecruitingObservational study
Pain Phenotypes in Individuals With Multiple Sclerosis
Multiple Sclerosis, Chronic Pain
Not yet recruiting
Effects of Hip Hinge Exercises on Pain, Range of Motion and Functional Disability in Non-specific Low Back Pain.
Low Back Pain
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Guzide UGUCU principal investigator
Mersin University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing 10% Oral Dextrose Solution, 20% Oral Dextrose Solution and 30% Oral Dextrose Solution in people with Pain, run by Guzide UGUCU at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pain will be measured by N-PASS (time frame: at the heel punction during heel-stick sampling). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05177263, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2024.